| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $19.5M | -57.9% |
| SG&A Expense | $17.0M | +16.0% |
| Operating Income | -$36.5M | +35.0% |
| Interest Expense | $90K | -70.7% |
| Income Tax | $0 | — |
| Net Income | -$39.0M | +26.5% |
| EPS (Basic) | -$50.83 | -3840.3% |
| EPS (Diluted) | -$50.83 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.9M | +26.2% |
| Current Assets | $52.1M | +17.9% |
| Total Assets | $53.0M | +17.3% |
| Current Liabilities | $10.1M | -33.8% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $10.5M | -35.9% |
| Stockholders' Equity | $42.5M | +47.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.3M | +40.4% |
| Financing Cash Flow | $43.5M | +2780.7% |
| -3840.3% |